Published in J Infect Dis on September 04, 2013
Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities. Gastroenterology (2014) 1.16
Activation and alliance of regulatory pathways in C. albicans during mammalian infection. PLoS Biol (2015) 1.14
The Cryptococcus neoformans transcriptome at the site of human meningitis. MBio (2014) 1.11
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans. J Immunol (2015) 0.97
Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment. PLoS One (2016) 0.87
RNA Enrichment Method for Quantitative Transcriptional Analysis of Pathogens In Vivo Applied to the Fungus Candida albicans. MBio (2015) 0.86
Metabolism in fungal pathogenesis. Cold Spring Harb Perspect Med (2014) 0.86
Candida glabrata intra-abdominal candidiasis is characterized by persistence within the peritoneal cavity and abscesses. Infect Immun (2014) 0.84
pH signaling in human fungal pathogens: a new target for antifungal strategies. Eukaryot Cell (2014) 0.82
Relationship between expression and methylation of obesity-related genes in children. Mutagenesis (2015) 0.81
Divergent targets of Aspergillus fumigatus AcuK and AcuM transcription factors during growth in vitro versus invasive disease. Infect Immun (2014) 0.81
Morphogenesis is not required for Candida albicans-Staphylococcus aureus intra-abdominal infection-mediated dissemination and lethal sepsis. Infect Immun (2014) 0.78
Morphology-Independent Virulence of Candida Species during Polymicrobial Intra-abdominal Infections with Staphylococcus aureus. Infect Immun (2015) 0.77
In Vivo Transcriptional Profiling of Human Pathogenic Fungi during Infection: Reflecting the Real Life? PLoS Pathog (2016) 0.76
Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework. Infect Immun (2016) 0.76
Coordination of Candida albicans Invasion and Infection Functions by Phosphoglycerol Phosphatase Rhr2. Pathogens (2015) 0.76
Novel Approaches for Fungal Transcriptomics from Host Samples. Front Microbiol (2016) 0.75
Candida albicans Transcriptional Profiling Within Biliary Fluid From a Patient With Cholangitis, Before and After Antifungal Treatment and Surgical Drainage. Open Forum Infect Dis (2016) 0.75
Pathogen Gene Expression Profiling During Infection Using a Nanostring nCounter Platform. Methods Mol Biol (2016) 0.75
Gene Expression Profiling of Infecting Microbes Using a Digital Bar-coding Platform. J Vis Exp (2016) 0.75
Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-Abdominal Abscess Model. Antimicrob Agents Chemother (2017) 0.75
Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol (2008) 15.90
Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev (2003) 4.07
RIM101-dependent and-independent pathways govern pH responses in Candida albicans. Mol Cell Biol (2000) 3.45
Candida albicans RIM101 pH response pathway is required for host-pathogen interactions. Infect Immun (2000) 3.03
Transcriptional profiling in Candida albicans reveals new adaptive responses to extracellular pH and functions for Rim101p. Mol Microbiol (2004) 2.03
Effect of environmental pH on morphological development of Candida albicans is mediated via the PacC-related transcription factor encoded by PRR2. J Bacteriol (1999) 1.98
Organ-specific innate immune responses in a mouse model of invasive candidiasis. J Innate Immun (2010) 1.94
Establishment of an experimental model of a Staphylococcus aureus abscess in mice by use of dextran and gelatin microcarriers. J Med Microbiol (1989) 1.89
Self-regulation of Candida albicans population size during GI colonization. PLoS Pathog (2007) 1.85
Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infect Immun (2002) 1.82
Candida albicans transcription factor Rim101 mediates pathogenic interactions through cell wall functions. Cell Microbiol (2008) 1.76
Invasive candidiasis. Infect Dis Clin North Am (2006) 1.75
Candida infections in surgical patients. Ann Surg (1983) 1.63
Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect Immun (2007) 1.59
Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet (1989) 1.53
Portrait of Candida albicans adherence regulators. PLoS Pathog (2012) 1.51
Infection-related gene expression in Candida albicans. Curr Opin Microbiol (2007) 1.50
Adaptations of Candida albicans for growth in the mammalian intestinal tract. Eukaryot Cell (2010) 1.32
Divergent targets of Candida albicans biofilm regulator Bcr1 in vitro and in vivo. Eukaryot Cell (2012) 1.30
Candida peritonitis. Curr Opin Crit Care (2007) 1.21
Cleavage of immunoglobulins by pathogenic yeasts of the genus Candida. Microbiol Sci (1986) 1.21
Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans. Microbiology (2008) 1.19
Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med (2002) 1.15
Transcriptional regulators Cph1p and Efg1p mediate activation of the Candida albicans virulence gene SAP5 during infection. Infect Immun (2002) 1.15
Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother (2002) 1.11
Limited role of secreted aspartyl proteinases Sap1 to Sap6 in Candida albicans virulence and host immune response in murine hematogenously disseminated candidiasis. Infect Immun (2010) 1.09
Degradation of humoral host defense by Candida albicans proteinase. Infect Immun (1995) 1.09
Critical issues in the clinical management of complicated intra-abdominal infections. Drugs (2005) 1.05
Disruption of the human pathogenic yeast Candida albicans catalase gene decreases survival in mouse-model infection and elevates susceptibility to higher temperature and to detergents. Microbiol Immunol (2003) 1.00
Inflammatory processes in a murine model of intra-abdominal abscess formation. J Leukoc Biol (1999) 0.96
Delayed clearance of intraabdominal abscesses caused by Candida albicans in tumor necrosis factor-alpha- and lymphotoxin-alpha-deficient mice. J Infect Dis (2002) 0.92
Candida peritonitis: an update on the latest research and treatments. World J Surg (2011) 0.90
The RIM101 signal transduction pathway regulates Candida albicans virulence during experimental keratomycosis. Invest Ophthalmol Vis Sci (2010) 0.89
Multifocal Candida species colonization as a trigger for early antifungal therapy in critically ill patients: what about other risk factors for fungal infection? Crit Care Med (2006) 0.87
Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party. Intensive Care Med (1994) 0.85
Tec1p-independent activation of a hypha-associated Candida albicans virulence gene during infection. Infect Immun (2004) 0.84
Pathogenesis of intraabdominal abscess formation: abscess-potentiating agents and inhibition of complement-dependent opsonization of abscess-inducing bacteria. J Infect Dis (1991) 0.84
Effectiveness of fluconazole in murine Candida albicans and bacterial C. albicans peritonitis and abscess formation. J Med Vet Mycol (1995) 0.80
Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor. Antimicrob Agents Chemother (2003) 0.79
Candida species. Insignificant contaminant or pathogenic species. Am Surg (1986) 0.79
Complementation of Saccharomyces cerevisiae mutations in genes involved in translation and protein folding (EFB1 and SSB1) with Candida albicans cloned genes. Res Microbiol (2000) 0.78
The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation. Am Surg (1995) 0.77
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov (2008) 7.64
Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol (2005) 4.97
Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog (2006) 3.58
Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol (2009) 3.20
A human-curated annotation of the Candida albicans genome. PLoS Genet (2005) 3.04
Candida albicans Mds3p, a conserved regulator of pH responses and virulence identified through insertional mutagenesis. Genetics (2002) 2.71
How to build a biofilm: a fungal perspective. Curr Opin Microbiol (2006) 2.69
In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J Clin Invest (2009) 2.53
Complementary adhesin function in C. albicans biofilm formation. Curr Biol (2008) 2.41
Genetic control of Candida albicans biofilm development. Nat Rev Microbiol (2010) 2.39
The transcription factor Rim101p governs ion tolerance and cell differentiation by direct repression of the regulatory genes NRG1 and SMP1 in Saccharomyces cerevisiae. Mol Cell Biol (2003) 2.29
Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell (2006) 2.21
Real-time fMRI of temporolimbic regions detects amygdala activation during single-trial self-induced sadness. Neuroimage (2003) 2.09
Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland. J Urol (2009) 2.03
Genetics and genomics of Candida albicans biofilm formation. Cell Microbiol (2006) 1.98
Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia. Antimicrob Agents Chemother (2005) 1.97
Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target. J Infect Dis (2010) 1.96
Multivesicular body-ESCRT components function in pH response regulation in Saccharomyces cerevisiae and Candida albicans. Mol Biol Cell (2004) 1.93
A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog (2012) 1.88
The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy. Clin Infect Dis (2006) 1.88
Candida albicans biofilm-defective mutants. Eukaryot Cell (2005) 1.87
Candida albicans transcription factor Rim101 mediates pathogenic interactions through cell wall functions. Cell Microbiol (2008) 1.76
An extensive circuitry for cell wall regulation in Candida albicans. PLoS Pathog (2010) 1.73
Outcomes of central nervous system cryptococcosis vary with host immune function: results from a multi-center, prospective study. J Infect (2010) 1.67
Roles of Candida albicans Dfg5p and Dcw1p cell surface proteins in growth and hypha formation. Eukaryot Cell (2003) 1.65
Age-specific complications among lung transplant recipients 60 years and older. J Heart Lung Transplant (2010) 1.61
Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro. Infect Immun (2004) 1.59
Control of the C. albicans cell wall damage response by transcriptional regulator Cas5. PLoS Pathog (2006) 1.57
Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD). Kidney Int (2005) 1.55
Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. Eur Arch Psychiatry Clin Neurosci (2008) 1.55
Portrait of Candida albicans adherence regulators. PLoS Pathog (2012) 1.51
Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure. Antimicrob Agents Chemother (2013) 1.49
The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata. Antimicrob Agents Chemother (2012) 1.47
Requirement for Candida albicans Sun41 in biofilm formation and virulence. Eukaryot Cell (2007) 1.46
Evaluation of the roles of four Candida albicans genes in virulence by using gene disruption strains that express URA3 from the native locus. Infect Immun (2003) 1.45
Five-minute exposure to caspofungin results in prolonged postantifungal effects and eliminates the paradoxical growth of Candida albicans. Antimicrob Agents Chemother (2011) 1.45
Gender differences in the cognitive control of emotion: An fMRI study. Neuropsychologia (2007) 1.44
Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin. Antimicrob Agents Chemother (2013) 1.44
Relationship of DFG16 to the Rim101p pH response pathway in Saccharomyces cerevisiae and Candida albicans. Eukaryot Cell (2005) 1.43
Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis (2013) 1.42
Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis (2012) 1.42
Multidimensional assessment of empathic abilities: neural correlates and gender differences. Psychoneuroendocrinology (2010) 1.41
[Evidence-based treatment of depression: what does the new S3- and national healthcare guideline Unipolar Depression really recommend?]. Z Psychosom Med Psychother (2010) 1.40
PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD). Hum Mutat (2004) 1.40
Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients. PLoS One (2012) 1.40
Control of Bro1-domain protein Rim20 localization by external pH, ESCRT machinery, and the Saccharomyces cerevisiae Rim101 pathway. Mol Biol Cell (2006) 1.39
Brain structure anomalies in autism spectrum disorder--a meta-analysis of VBM studies using anatomic likelihood estimation. Hum Brain Mapp (2011) 1.39
High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen. Diagn Microbiol Infect Dis (2011) 1.38
Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments. Antimicrob Agents Chemother (2006) 1.34
Chemical biology investigation of cell death pathways activated by endoplasmic reticulum stress reveals cytoprotective modulators of ASK1. J Biol Chem (2008) 1.33
Predicting delirium after vascular surgery: a model based on pre- and intraoperative data. Ann Surg (2003) 1.33
Alcohol dehydrogenase restricts the ability of the pathogen Candida albicans to form a biofilm on catheter surfaces through an ethanol-based mechanism. Infect Immun (2006) 1.33
Anthrax lethal toxin paralyzes neutrophil actin-based motility. J Infect Dis (2005) 1.32
Divergent targets of Candida albicans biofilm regulator Bcr1 in vitro and in vivo. Eukaryot Cell (2012) 1.30
Same or different? Neural correlates of happy and sad mood in healthy males. Neuroimage (2005) 1.30
The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother (2012) 1.27
Fungal biofilms. PLoS Pathog (2012) 1.26
Cell wall integrity is linked to mitochondria and phospholipid homeostasis in Candida albicans through the activity of the post-transcriptional regulator Ccr4-Pop2. Mol Microbiol (2010) 1.26
Deformation field morphometry reveals age-related structural differences between the brains of adults up to 51 years. J Neurosci (2008) 1.25
Pharmacokinetic/pharmacodynamic profile of posaconazole. Clin Pharmacokinet (2010) 1.25
The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases. Cancer Cytopathol (2012) 1.24
Genetic load on amygdala hypofunction during sadness in nonaffected brothers of schizophrenia patients. Am J Psychiatry (2004) 1.24
Role of filamentation in Galleria mellonella killing by Candida albicans. Microbes Infect (2010) 1.23
Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates. Antimicrob Agents Chemother (2014) 1.21
Candida albicans protein kinase CK2 governs virulence during oropharyngeal candidiasis. Cell Microbiol (2006) 1.21
Role of Bcr1-activated genes Hwp1 and Hyr1 in Candida albicans oral mucosal biofilms and neutrophil evasion. PLoS One (2011) 1.20
Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia. J Clin Psychiatry (2007) 1.19
Generalized deficit in all core components of empathy in schizophrenia. Schizophr Res (2008) 1.19
BI-1 regulates endoplasmic reticulum Ca2+ homeostasis downstream of Bcl-2 family proteins. J Biol Chem (2008) 1.19
Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol (2007) 1.18
Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts. J Clin Microbiol (2007) 1.17
The Cryptococcus neoformans Rim101 transcription factor directly regulates genes required for adaptation to the host. Mol Cell Biol (2013) 1.16
Candida albicans Rim13p, a protease required for Rim101p processing at acidic and alkaline pHs. Eukaryot Cell (2004) 1.16
Regulation of the Candida albicans cell wall damage response by transcription factor Sko1 and PAS kinase Psk1. Mol Biol Cell (2008) 1.15
Aspergillus galactosaminogalactan mediates adherence to host constituents and conceals hyphal β-glucan from the immune system. PLoS Pathog (2013) 1.15
Increased neural response related to neutral faces in individuals at risk for psychosis. Neuroimage (2007) 1.15
Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum. Antimicrob Agents Chemother (2011) 1.15
Posaconazole serum concentrations among cardiothoracic transplant recipients: factors impacting trough levels and correlation with clinical response to therapy. Antimicrob Agents Chemother (2010) 1.15
White-matter abnormalities in Tourette syndrome extend beyond motor pathways. Neuroimage (2010) 1.14
Yeast wall protein 1 of Candida albicans. Microbiology (2005) 1.14